ClearPoint Neuro Q4 Sales $4.30M Up From $3.72M YoY
ClearPoint Neuro (NASDAQ:CLPT) reported $4.30 million in sales this quarter. This is a 15.72 percent increase over sales of $3.72 million the same period last year.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Longeveron (NASDAQ:LGVN) shares rose 7.69% to $3.64 during Monday's after-market session. The company's market cap stands at $69.5 million.
66 Biggest Movers From Yesterday
Gainers
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share.
ClearPoint Neuro Stock Dives After Q2 Earnings
ClearPoint Neuro Inc (NASDAQ:CLPT) reported Q2 revenue of $3.4 million, a 38% Y/Y increase, below the consensus estimate of $3.68…
Recap: ClearPoint Neuro Q2 Earnings
Shares of ClearPoint Neuro (NASDAQ:CLPT) decreased in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 54.55% year over year to ($0.17), which missed the estimate of ($0.13).